Cullinan Therapeutics Inc.
CGEM | NASDAQ
$21.53
+$0.18 (+0.84%)
Sep 22, 2026, 10:58 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -103.37M | -49.66M | -50.71M | -50.61M | -70.06M | -48.5M | -47.65M | -40.56M | -42.03M | -37.15M | -23.8M | -39.18M | -32.21M | -58.14M | -26.78M | -24.8M | 174.9M | -12.89M | -32.51M | -17.35M | -16.44M | 1.42M |
Depreciation & Amortization | 158K | 79K | 79K | 79K | 77K | 76K | 77K | 76K | 77K | 76K | 77K | 80K | 81K | 72K | 59K | 9K | 12K | 13K | 12K | 13K | 13K | 15K |
Stock-Based Compensation | 16.06M | 7.62M | 7.31M | 9.47M | 9.89M | 9.37M | 9.63M | 9.43M | 10.53M | 8.23M | 7.52M | 7.74M | 7.92M | 7.26M | 7.51M | 5.27M | 8.61M | 6.57M | 12.15M | 4.56M | 4.17M | 3.51M |
Other Working Capital | 1.33M | -4.97M | 7.02M | 6.28M | 5.13M | -3.51M | 5.26M | 1.28M | 1M | -7.12M | 1.77M | 1.36M | -5.11M | 1.81M | -6.16M | -33.33M | 4.78M | -109K | 4.61M | 1.7M | -2.45M | -2.56M |
Other Non-Cash Items | -1.33M | -777K | -931K | -1.36M | -1.71M | -2.31M | -3.51M | -4.93M | -3.73M | -3.5M | 897K | -3.2M | -2.15M | -1.37M | 6.75M | 5.36M | -213.72M | 946K | 11.58M | 4.57M | 885K | 229K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.13M | 607K | n/a | n/a | n/a | n/a | n/a | -19.57M | n/a | n/a | n/a | n/a |
Change in Working Capital | 4.21M | -3.3M | 6.14M | 5.55M | 4.19M | -1.79M | 4.82M | 1.84M | -1.15M | -5.9M | 3.31M | -181K | -4.65M | 1.18M | -5.01M | -34.91M | 4.78M | 3.03M | 5.75M | 2.21M | -4.82M | -6.69M |
Operating Cash Flow | -84.26M | -46.05M | -38.11M | -36.88M | -57.61M | -43.16M | -36.63M | -34.14M | -36.29M | -38.25M | -18.13M | -34.14M | -31.01M | -51M | -24.98M | -54.35M | -25.42M | -21.91M | -15.17M | -10.55M | -16.2M | -1.52M |
Capital Expenditures | n/a | n/a | -11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -49K | -159K | -882K | -251K | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 275.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -34.71M | -20.14M | -19.6M | -12.57M | -78.53M | -125.84M | -168.04M | -96.8M | -324.93M | -131.37M | -66.01M | -136.78M | -81.45M | -89.14M | -160.42M | -124.13M | -36.35M | -57.02M | -77.26M | -85.3M | -213.49M | -149.76M |
Sales Maturities Of Investments | 107.8M | 52.55M | 42M | 80M | 131.93M | 162.65M | 184M | 116.68M | 139.82M | 144.33M | 117.48M | 93.82M | 93.61M | 104.48M | 132.6M | 61.4M | 67.2M | 91.73M | 61.4M | 59.71M | 58.9M | 12.04M |
Other Investing Acitivies | n/a | n/a | n/a | -38K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -275M | 5M | 300.85M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 73.09M | 32.41M | 22.39M | 67.39M | 53.4M | 36.81M | 15.96M | 19.88M | -185.11M | 12.96M | 51.47M | -42.96M | 12.11M | 15.18M | -28.61M | -57.98M | 300.85M | 34.71M | -15.86M | -25.59M | -154.59M | -137.73M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.83M | -2.2M | n/a | -800K | 800K | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -656K | -3.79M | n/a | n/a | -178K | 214K | -36K | -33.28M | n/a | n/a | 2.74M | n/a | n/a | 923K | -2.69M |
Financial Cash Flow | 1.48M | 380K | 715K | n/a | 373K | n/a | 1.58M | 1.33M | 262.2M | 1.09M | 248K | 112K | 38.6M | 1.79M | -32.91M | 1.43M | 2.01M | 3.54M | 2.7M | 579K | 923K | 264.58M |
Net Cash Flow | -9.69M | -13.25M | -15M | 30.52M | -3.84M | -6.35M | -19.08M | -12.94M | 40.79M | -24.21M | 33.59M | -76.99M | 19.71M | -34.02M | -86.51M | -110.91M | 277.45M | 16.34M | -28.33M | -35.57M | -169.87M | 125.34M |
Free Cash Flow | -84.26M | -46.05M | -38.12M | -36.92M | -57.61M | -43.16M | -36.63M | -34.14M | -36.29M | -38.25M | -18.13M | -34.14M | -31.06M | -51.16M | -25.87M | -54.6M | -25.42M | -21.91M | -15.17M | -10.55M | -16.2M | -1.52M |
Adj. Free Cash Flow | -100.33M | -53.66M | -45.43M | -46.38M | -67.5M | -52.53M | -46.26M | -43.57M | -46.82M | -46.47M | -25.65M | -41.88M | -38.98M | -58.42M | -33.38M | -59.88M | -34.03M | -28.47M | -27.32M | -15.11M | -20.36M | -5.02M |
Maintenance CapEx | n/a | n/a | -11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -49K | -159K | -882K | -251K | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -84.26M | -46.05M | -38.12M | -36.88M | -57.61M | -43.16M | -36.63M | -34.14M | -36.29M | -38.25M | -18.13M | -34.14M | -31.06M | -51.16M | -25.87M | -54.6M | -25.42M | -21.91M | -15.17M | -10.55M | -16.2M | -1.52M |
Add to Watchlist
Select watchlists to add or remove CGEM